EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?

Marwa Abdel Hamid, Lorenz M Pammer, Theresa K Lentner, Bernhard Doleschal, Rebecca Gruber, Florian Kocher, Elisabeth Gasser, Anna Jöbstl, Andreas Seeber, Arno Amann

Current Oncology Reports · 2024-10 · 26 (10) · 1258-1270

DOI: 10.1007/s11912-024-01583-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology Reports, online erschienen am 30.07.2024. Verfasst von Marwa Abdel Hamid und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Aust…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Microsatellite Instability, Immune Checkpoint Inhibitors, Immunotherapy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Innsbruck and Medical University of Innsbruck.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review This review will explore various strategies to rendering MSS mCRCs susceptible to ICI. Moreover, we will provide an overview of potential biomarkers that may aid to better patient selection, and discuss ongoing efforts in this area of research. Recent Findings Colorectal cancer (CRC) ranks among the top three most common cancers worldwide. While significant advances in treatment strategies have improved the prognosis for patients in the early stages of the disease, treatment options for metastatic CRC (mCRC) remain limited. Although immune checkpoint inhibitors (ICI) have revolutionized the treatment of several malignancies, its efficacy in mCRC is largely confined to patients exhibiting a high microsatellite instability status (MSI-H). However, the vast majority of mCRC patients do not exhibit a MSI-H, but are microsatellite stable (MSS). In these patients ICIs are largely ineffective. Summary So far, ICIs do not play a crucial role in patients with MSS mCRC, despite the promising data for inducing long-term remissions in other tumour entities. For this reason, novel treatment strategies are needed to overcome the primary resistance upon ICI in patients with MSS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicrosatellite InstabilityImmune Checkpoint InhibitorsImmunotherapyHumansNeoplasm MetastasisBiomarkers, Tumor

Stichwörter der Autor:innen

BiomarkerColorectal cancerImmunotherapyMicrosatellite instabilityMicrosatellite stable

Substanzen

Immune Checkpoint InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria.
  • Department of Gastroenterology and Hepatology, Medical University of Innsbruck, Innsbruck, Austria.
  • Clinical Department for Internal Medicine, University Hospital St. Poelten, Karl Landsteiner University of Health Sciences, St. Poelten, Austria.
  • Department of Internal Medicine I for Hematology With Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz, Linz, Austria.
  • Medical Faculty, Johannes Kepler University Linz, Linz, Austria.
  • Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Förderung

  • University of Innsbruck and Medical University of Innsbruck

Zitieren

APA

Hamid, M. A., Pammer, L. M., Lentner, T. K., Doleschal, B., Gruber, R., Kocher, F., Gasser, E., Jöbstl, A., Seeber, A., & Amann, A. (2024). Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?. Current Oncology Reports, 26(10), 1258-1270. https://doi.org/10.1007/s11912-024-01583-w

Vancouver

Hamid MA, Pammer LM, Lentner TK, Doleschal B, Gruber R, Kocher F, et al. Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?. Current Oncology Reports. 2024;26(10):1258-1270. doi:10.1007/s11912-024-01583-w

BibTeX
@article{Hamid2024,
  author = {Hamid, Marwa Abdel and Pammer, Lorenz M and Lentner, Theresa K and Doleschal, Bernhard and Gruber, Rebecca and Kocher, Florian and Gasser, Elisabeth and Jöbstl, Anna and Seeber, Andreas and Amann, Arno},
  title = {Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?},
  journal = {Current Oncology Reports},
  year = {2024},
  volume = {26},
  number = {10},
  pages = {1258--1270},
  doi = {10.1007/s11912-024-01583-w}
}
Kostenlos starten →